Concepedia
Statistics
Publications
6
Citations
288
H-Index
Active since
2011
Affiliations
Vanderbilt University(Current)
Harvard University
Dana-Farber Cancer Institute
Helen DeVos Children's Hospital
Van Andel Institute
Matt L. Harlow is an author at Vanderbilt University specializing in molecular oncology, oncology, and medicine.
Publications per year
2011–2021
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus
Matt L. Harlow, Nichole Maloney, Joseph T. Roland et al. · Cancer Research · 2016 · 92 citations · Full text
Medicine, Molecular Biology, Oncology +14
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner
Matt L. Harlow, Maggie H. Chassé, Elissa A. Boguslawski et al. · Clinical Cancer Research · 2019 · 57 citations · Full text
Medicine, Cancer Biology, Oncology +17
Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma
Patrick J. Grohar, Sun Tae Kim, Guillermo O. Rangel Rivera et al. · Cell Reports · 2016 · 52 citations · Full text
Life Sciences, Genetics, Molecular Biology +17
Forty-five patient-derived xenografts capture the clinical and biological heterogeneity of Wilms tumor
Andrew J. Murphy, Xiang Chen, Emília M. Pinto et al. · Nature Communications · 2019 · 52 citations · Full text
Chromatin modifying protein 1A (Chmp1A) of the endosomal sorting complex required for transport (ESCRT)-III family activates ataxia telangiectasia mutated (ATM) for PanC-1 cell growth inhibition
Sumanth Manohar, Matt L. Harlow, H. V. Nguyen et al. · Cell Cycle · 2011 · 18 citations · Full text
Life Sciences, Cell Biology, Genetics +12
1–5 of 6